Last reviewed · How we verify

NCT06902610: POPPINS-02-B

Examining the Medium-term Effect on Non Inferiority of the Previous Training With the DMD Poppins Clinical for Cognitive, Musical Training in Addition to Bi-monthly Speech and Reading Therapy on Reading Writing Abilities of Pediatric Patients With SLD Reading VS Control Group

Recruiting now Last updated 2 July 2025
What this trial tests

trial testing Poppins Clinical in Learning Disorder, Specific in 306 participants. Currently enrolling.

Timeline
20 June 2025
Primary endpoint
15 April 2026
15 April 2026

Quick facts

Lead sponsorPoppins
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment306
Start date20 June 2025
Primary completion15 April 2026
Estimated completion15 April 2026
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Poppins

Who can join

Adults 7 to 11, any sex, with Learning Disorder, Specific or Learning Disability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Poppins-02-b is an observational follow-up study examining the medium-term effect on non-inferiority of the previous training with the digital medical device (DMN) Poppins Clinical for cognitive and musical training in addition to bi-monthly speech and reading therapy sessions on the reading and writing abilities of pediatrics patients with specific learning disorders involving reading and/or writing deficits compared to a control group that received weekly speech and reading therapy sessions. Poppins-02-b is an ancillary study to Poppins-02 and consists of monitoring patients who participated in Poppins-02 study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Poppins Clinical

Trials testing the same drug.

Other Poppins trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06902610.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing